Health & Pharm General

Anatara Lifesciences Ltd (ASX:ANR) Chairman's Address and AGM Presentation

🕔11/11/2019 11:29:07 AM

As Anatara moves forward, the Board is confident in the knowledge that a substantial market opportunity for Detach(R) remains, with more pressure than ever on producers to reduce their antibiotic use and find suitable alternatives which minimise illnesses, such as scour, on farms.

Read Full Article

Cann Global Limited (ASX:CGB) T12 Food Division Update

🕔11/11/2019 8:34:56 AM

The Food management team at T12, are proud to announce the release of our new and nutritious 'Black Label' Hemp Seed Oil and Hemp Seed mixes product range for the discerning Australian and Asian consumer.

Read Full Article

Cann Global Limited (ASX:CGB) Institutional Investment to Support Expansion

🕔11/5/2019 9:46:44 AM

Cann Global Ltd (ASX:CGB) is pleased to advise that the Company has secured further institutional support from New York based L1 Capital Global Opportunities Master Fund ("L1" or "Investor"). The Company has agreed to issue 2,600,000 secured convertible notes (Notes) to raise $2.22M after costs.

Read Full Article

Cann Global Limited (ASX:CGB) September Quarterly Report

🕔11/1/2019 8:08:16 AM

Cann Global Limited (ASX:CGB) presents its Quarterly report for the three months ended 30 September 2019.

Read Full Article

Regeneus Ltd (ASX:RGS) Quarterly Report

🕔10/31/2019 1:38:20 PM

Regeneus Ltd (ASX:RGS) (Regeneus or the Company), a clinical-stage regenerative medicine company, today released its quarterly cashflow report for the period ending 30 September 2019 (Q1 FY20).

Read Full Article

Bluechiip Ltd (ASX:BCT) Share Purchase Plan (SPP) Offer Documents

🕔10/30/2019 9:24:58 AM

Bluechiip Ltd (ASX:BCT) is offering Eligible Shareholders the opportunity to participate in the Bluechiip Share Purchase Plan (SPP).

Read Full Article

Bluechiip Ltd (ASX:BCT) Completion of Institutional Placement

🕔10/30/2019 9:10:08 AM

Bluechiip Limited (ASX:BCT) is pleased to confirm that, further to its ASX Release dated 24 October 2019, the Company has now completed the institutional share placement (Placement) of new fully paid ordinary shares.

Read Full Article